News | News By Subject | News by Disease News By Date | Search News

Liver cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH     11/14/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure     9/28/2016
Bayer (BAY)'s Regorafenib Extends Lives of Liver Cancer Patients in Late Stage Study     5/5/2016
The Three Most Important Drugs in Gilead (GILD)'s Pipeline     12/8/2015
Raptor (RPTP)'s Phase IIb CyNCh Study Fails To Meet Primary Endpoint, Shares Skid     9/15/2015
AbbVie (ABBV)’s Viekira Pak Clears Another Hurdle, 100% HCV-1b Clearance Rate in Phase III Trial     6/25/2015
La Jolla Pharma (LJPC) Bails On Two Drug Programs, Shifts Focus to Rare Disease     5/11/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results     3/27/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Tekmira (TKMR) Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals (DRNA)     11/17/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen     10/24/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi     10/9/2014

News from Around the Web
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Broccoli May Protect Against Liver Cancer, University of Illinois Study Shows     3/4/2016
Nanoparticle Therapy That Uses LDL And Fish Oil Kills Liver Cancer Cells, UT Southwestern Medical Center Study     2/9/2016
Studying Cancer DNA In Blood May Help Personalize Treatment In Liver Cancer, Hiroshima University Reveals     11/3/2015
Prolonged TV Watching Linked To Eight Leading Causes Of Death, American Journal of Preventive Medicine Publishes     10/28/2015
Could Image Mapping Offer Way To Do Noninvasive Liver Biopsies?     10/20/2015
New DNA Testing For Liver Cancer Could Improve Survival, Hiroshima University Study     9/11/2015
Citrus Scent Could Help Fight Liver Cancer, Ruhr-University Study     1/21/2015
Herbal Medicines Could Contain Dangerous Levels Of Toxic Mold, University Of Peshawar     10/27/2014
A Genetic Catch-22 Promotes and Prevents Liver Cancer, University of Southern California Study     8/7/2013
Breakthrough Chemo Bath Treats Liver Cancer for First Time in UK, Southampton General Hospital Reveals     11/12/2012
Metabolic Syndrome Increases Risk of Both Major Types of Primary Liver Cancer, National Cancer Institute Study     7/28/2011
Experts at University of Hong Kong Find Rogue Stem Cells in Liver Cancer     7/7/2011
Six-Year Study Confirms Australia's Sirtex Medical's Liver Cancer Therapy is Safe and Effective     7/7/2011
Discovery in Liver Cancer Cells Provides New Target for Drugs, Virginia Commonwealth University Study     3/23/2011

Press Releases
Mallinckrodt (MNK) Release: Clinical Data Analysis On Terlipressin Presented At The Liver Meeting     11/17/2016
American Medical Association's USAN & WHO's INN Approve "Namodenoson" As Generic Name For Can-Fite BioPharma (CFBI)'s Liver Drug CF102     11/16/2016
Bayer (BAY) Submits Supplemental New Drug Application For Stivarga (regorafenib) For Advanced Liver Cancer     11/7/2016
Medivir (MVRBF)’s Nucleotide Polymerase Inhibitor For The Treatment Of Liver Cancer, MIV-818, Enters Non-Clinical Development     11/1/2016
Can-Fite BioPharma (CFBI) Signs Distribution Deal For Liver Cancer Drug CF102 In South Korea     10/25/2016
BTG plc (BTG.L) Release: First Patient In Malaysia Receives TheraSphere Radioembolisation Therapy     10/4/2016
Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer     10/4/2016
Can-Fite BioPharma (CFBI) Reports New Data On CF102's Liver Protective & Regenerative Properties Published In Scientific Journal     9/20/2016
Liver Cancer Treatment Using Surefire Technology Results In 92% Objective Response Rate     9/12/2016
twoXAR Sets Sights On Liver Cancer With New Collaboration     9/8/2016
Exelixis (EXEL) Announces Outcome From First Planned Interim Analysis Of The Phase III CELESTIAL Trial Of Cabozantinib In Patients With Advanced Hepatocellular Carcinoma     9/7/2016
Phase III Data Show Bayer (BAY)'s Stivarga (Regorafenib) Improved Overall Survival In Previously Treated Patients With Unresectable Liver Cancer     6/28/2016
Asia-Pacific Hepatocellular Carcinoma Trials Group (AHCC) Release: SIRveNIB, A Major Primary Liver Cancer Study In The Asia-Pacific Region, Completes Enrollment     6/6/2016
MiNA Announces Initiation Of Phase I Clinical Study Of MTL-CEBPA In Patients With Liver Cancer     6/2/2016
Can-Fite BioPharma (CFBI) Reports First Quarter 2016 Financial Results & Provides Clinical Pipeline Update     5/27/2016

//-->